Literature DB >> 12163040

Targeted disruption of one allele of the Y-box protein gene, Chk-YB-1b, in DT40 cells results in major defects in cell cycle.

Shivalingappa K Swamynathan1, Balwantkumar R Varma, Karl T Weber, Ramareddy V Guntaka.   

Abstract

Y-box or inverted CCAAT box-binding proteins are multifunctional regulators of transcription and translation of several genes. Although YB-1 has been shown to play a key role in cell cycle, to date, there is no direct evidence. We disrupted one allele of Chk-YB-1b in a chicken pre-B lymphocyte cell line, DT40. Compared to wild-type DT40 cells, these heterozygous DT40YB1b(+/-) cells with one copy of the wild-type Chk-YB-1b allele showed multiple abnormalities, which include slower rate of growth, abnormal cell morphology, increased cell size, and increased genomic DNA content. These phenotypic defects resemble those cells that have a block in G2 and/or mitosis (G2/M). In addition, we have observed that a fraction of these heterozygous DT40YB1b(+/-) cells undergo apoptosis. In conclusion, we have discovered major defects in the G2/M phase of cell cycle in YB-1 knocked-out heterozygous mutant cells, providing for the first time direct evidence establishing a crucial role for YB-1 in cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12163040     DOI: 10.1016/s0006-291x(02)00875-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  An acidic protein, YBAP1, mediates the release of YB-1 from mRNA and relieves the translational repression activity of YB-1.

Authors:  Ken Matsumoto; Kimio J Tanaka; Masafumi Tsujimoto
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

2.  YB-1 is important for late-stage embryonic development, optimal cellular stress responses, and the prevention of premature senescence.

Authors:  Zhi Hong Lu; Jason T Books; Timothy J Ley
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

3.  Inhibition of protein synthesis by Y box-binding protein 1 blocks oncogenic cell transformation.

Authors:  Andreas G Bader; Peter K Vogt
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

4.  The N-terminal domain of y-box binding protein-1 induces cell cycle arrest in g2/m phase by binding to cyclin d1.

Authors:  Payal Khandelwal; Mythili K Padala; John Cox; Ramareddy V Guntaka
Journal:  Int J Cell Biol       Date:  2010-04-14

5.  Identification of Y-box binding protein 1 as a core regulator of MEK/ERK pathway-dependent gene signatures in colorectal cancer cells.

Authors:  Karsten Jürchott; Ralf-Jürgen Kuban; Till Krech; Nils Blüthgen; Ulrike Stein; Wolfgang Walther; Christian Friese; Szymon M Kiełbasa; Ute Ungethüm; Per Lund; Thomas Knösel; Wolfgang Kemmner; Markus Morkel; Johannes Fritzmann; Peter M Schlag; Walter Birchmeier; Tammo Krueger; Silke Sperling; Christine Sers; Hans-Dieter Royer; Hanspeter Herzel; Reinhold Schäfer
Journal:  PLoS Genet       Date:  2010-12-02       Impact factor: 5.917

6.  Significance of the Y-box proteins in human cancers.

Authors:  Ken Matsumoto; Boon-Huat Bay
Journal:  J Mol Genet Med       Date:  2005-08-03

Review 7.  YB-1 as an Oncoprotein: Functions, Regulation, Post-Translational Modifications, and Targeted Therapy.

Authors:  Qiyan Yin; Min Zheng; Qianmei Luo; Dewei Jiang; Huifeng Zhang; Ceshi Chen
Journal:  Cells       Date:  2022-04-04       Impact factor: 6.600

8.  Differential regulation of the serotonin transporter gene by lithium is mediated by transcription factors, CCCTC binding protein and Y-box binding protein 1, through the polymorphic intron 2 variable number tandem repeat.

Authors:  Julian Roberts; Alison C Scott; Mark R Howard; Gerome Breen; Vivien J Bubb; Elena Klenova; John P Quinn
Journal:  J Neurosci       Date:  2007-03-14       Impact factor: 6.167

9.  YB-1 is a Transcription/Translation Factor that Orchestrates the Oncogenome by Hardwiring Signal Transduction to Gene Expression.

Authors:  Joyce Wu; Anna L Stratford; Arezoo Astanehe; Sandra E Dunn
Journal:  Transl Oncogenomics       Date:  2007-05-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.